Realheart's CEO Ina Laura Perkins is invited to speak at the joint conference of the European Mechanical Circulatory Support and the International Society for Mechanical Circulatory Support in Hannover, Germany, in December.
The EUMS-ISMCS conference runs from the 1st 4th of December and Ina Laura Perkins' presentation on Realheart TAH will take place on December 3rd at 2 PM.
''Germany is one of the most important markets for artificial hearts in Europe and I am grateful to be able to raise awareness of our product and what makes it different from our competitors. Also, the conference brings together engineers, doctors, and biomedical researchers from all over the world. We get to meet future suppliers, partners, employees and customers," says Ina Laura Perkins, CEO of Realheart.
More information and a detailed programme can be found here: https://www.congresseums.com/
For more information please contact:
Ina Laura Perkins, CEO
Phone: +46(0)70 406 49 21
Scandinavian Real Heart AB develops a total artificial heart (TAH) for implantation in patients with life-threatening heart failure. Realheart TAH has a unique, patented design that resembles that of the natural human heart. The artificial heart consists of a four-chamber system (two atriums and two chambers) which provides the opportunity to generate a physiologically adapted blood flow that mimics the body's natural circulation. A unique concept in the medical technology world.Release (PDF)